Grants Review Working Group Members


Patient Advocates of the ICOC


Jonathan Thomas (ex-officio) ICOC Chairman
David Higgins ICOC Patient Advocate - Parkinson's Disease
Lauren Miller ICOC Patient Advocate - Alzheimer’s Disease
Francisco Prieto ICOC Patient Advocate - Type I Diabetes
Al Rowlett ICOC Patient Advocate - Mental Health
Jeff Sheehy ICOC Patient Advocate - HIV/AIDS
Oswald Steward ICOC Patient Advocate - Spinal Cord Injury
Art Torres ICOC Patient Advocate - Alternate
Diane Winokur ICOC Patient Advocate - ALS and Multiple Sclerosis




Gyula Acsadi The Children’s Hospital of Michigan Pediatric Neurology; Gene Therapy for Motor Neuron Disease
Julie Allickson Wake Forest School of Medicine Quality Assurance/Control, Regulatory Affairs, Process Development and GMP Manufacturing
Brenda Andrews University of Toronto Genomics; Phenomics: Cell Cycle Regulated Transcription
Ali Arbab Georgia Health Sciences University Imaging; Cell Tracking; Radiology; Oncology
Nazem Atassi Massachusetts General Hospital Translational Research and Clinical trials in Neurodegenerative Disorders
Alex Bailey REGENXBIO Inc. Nonclinical Regulatory; Pharmacology/Toxicology; Cell and Gene Therapy
Andrew Baker University of Edinburgh Cardiovascular Disease; Gene and Cell Therapy
Andrew Balber Cicada Biopharmaceutical Consulting Immunology, Cellular Therapeutics
Roger Barker University of Cambridge Neuroscience; PD; HD; Cell Therapy; Biomarkers, Neurogenesis
Julia Barrett Biologics Consulting Group, Inc. Clinical Consultant; Regulatory
Amelia Bartholomew University of Illinois-Chicago Hematopoietic & Mesenchymal Stem Cells; Transplantation Tolerance; Solid Organ Transplantation
Daniel Bauer Harvard Medical School Pediatric Hematology/Oncology; Therapeutic Genome Editing
Bradley Bernstein Massachusetts Institute of Technology Genomics Approaches to the Study of Chromatin Structure and Cancer
Alexey Bersenev Yale University CAR-T Cell Manufacturing; Hematopoietic Stem Cells; Immunotherapy
Mick Bhatia McMaster University Somatic & Pluripotent Stem Cell Development; Hematopoiesis
Lauren Black Charles River Laboratory Regulatory (Pharmacology / Toxicology)
Cesar Borlongan University of South Florida Cell Therapy for Brain Disorders Including Stroke and Neonatal Ischemic Injury
Michael Boulton University of Alabama School of Medicine Retinal Disease; Stem Cell Biology
Kenneth Brayman University of Virginia Health System Diabetes; Kidney & Islet Transplantation; Peripheral Vascualar Disease
Christopher Breuer Nationwide Children's Hospital Pediatric Surgery; Tissue Engineering; Vascular Biology
Vania Broccoli San Raffaele Scientific Institute Genetics & Neural Stem Cell Fate; Hereditory Neural Syndromes; Neurodevelopment
Ulrich Broeckel Medical College of Wisconsin Genetics & Cardiovascular Disease; Pharmacogenetics; iPSC Modeling
Patrik Brundin Van Andel Institute Neural Transplantation (PD)
Jeff Bulte John Hopkins University Cellular Imaging
Jason Burdick University of Pennsylvania Development of Hydrogels for Biologic Application
Joy Cavagnaro Access Bio Regulatory; Preclinical Development; Cell & Gene Therapy
John Centanni Neurona Therapeutics Clinical Product Development for Cellular Therapeutics
Linzhao Cheng Johns Hopkins University School of Medicine Stem Cell Models for Hematopoiesis and Blood Diseases; Gene Editing
Rajesh Chopra Institute of Cancer Research and Royal Marsden Hospital Oncology; Hematology; Stem Cells; Translational Medicine
Jose Cibelli Michigan State University Cellular Reprogramming; Stem Cell Biology; Pluripotency
Francesca Cicchetti Université Laval Neurodegenerative Disorders; Therapeutic Development; Stem Cell Therapies
Diego Correa University of Miami MSC Biology, Skeletal Joint Diseases, Diabetes
Chad Cowan Harvard University Stem Cell Biology, In vitro Models of Disease
Charles Cox, Jr University of Texas Medical School at Houston Pediatric Trauma; Neurologic Injury; Bio-hybrid Organs; Cardiopulmonary
Dennis Crawford Oregon Health & Science University Orthopedic Surgery; ACL Reconstruction
John Crowley Fred Hutchinson Cancer Center Design & Analysis of Cancer Clinical Trials
Linda Custer Tarveda Therapeutics Clinical Operations
Corey Cutler Harvard Medical School Hematology/Oncology; Cancer Immunology; Stem Cell Transplantation
Margot Damaser Cleveland Clinic Female Pelvic Dysfunction; Urinary & Fecal Incontinence; Pelvic Organ Prolapse
Carol Danielson Regulatory Advantage, LLC Clinical Regulatory; CMC Regulatory; Cell Therapy, Biologics, & Small Molecule Therapeutics
Cosimo de Bari University of Aberdeen Skeletal Repair; Potency Assays; Arthritis
Willard Dere University of Utah Clinical Development; Endocrine, Bone, & General Medicine Research & Development
John DiPersio Washington University School of Medicine Leukemias, Bone Marrow Transplantation
Daniel Doherty Seattle Children's Hospital Developmental Pediatrics; Genetics & Hindbrain Malformations
Boro Dropulic Lentigen Lentiviral Vector Technology; HIV/AIDS
Jay Edelberg Sanofi-Aventis Cardiovascular Disease Therapies, Biomarkers
James Ellis The Hospital for Sick Children Vector Development; Reprogramming; iPSC Banking; Rett Syndrome
Alan Flake Children's Hospital of Philadelphia In utero Cell & Gene Therapy; Pediatric Surgery
Thomas Freeman University of South Florida Neural Transplantation; Spine Surgery
Mark Furth Fibrolamellar Cancer Foundation Fetal & Adult Stem Cells in Regenerative Medicine
Glenn Gaudette Worcester Polytechnic Institute Biomedical Engineering, Cell Therapy, Cardiovascular Disease
Adrian Gee Baylor College of Medicine CMC for Cell and Gene Therapy, HSC, & Blood Bank Standards
Bruce Gelb Mount Sinai Hospital Pediatric Cardiology; Cardiomyopathy; Cardiovascular Genetics: Heart Transplantation
Manuela Gernert University of Veterinary Medicine Hannover Pathophysiology of Epilepsies; Neural Transplantation; Drug Delivery in Epilepsy
Richard Gibbs Baylor College of Medicine Genomics of Cancer, Heart Disease, & Autism
Rachel Gibson University of Adelaide Chemotherapy-Induced Mucositis; Gut Microbiome
Jonathan D. Glass Emory University Neuromuscular Disorders; Peripheral Neuropathies (ALS)
May Griffith Linkopings University Regenerative Medicine; Biomaterials; Eye (Cornea)
James Guest The Miami Project Spinal Cord Injury; Preclinical Animal Modeling
Christie Gunter HudsonAlpha Institute for Biotechnology Human Genetics & Genomics; Fragile X Syndrome
Kurt Gunter Cell Medica Inc. Regulatory Affairs, Therapy Development
Timothy Hacker University of Wisconsin Animal Models of Disease for Preclinical Testing
John Hassell McMaster University Cancer Biology (Breast); Therapeutics; Cell Signaling; Functional Genomics
Franz Hefti Proclara Biosciences Drug Development; Neuroscience (AD)
Derek Hei BlueRock Therapeutics Developing Cell and Gene Therapeutics for Clinical Trials; Cell Manufacturing
Shelly Heimfeld Fred Hutchinson Cancer Research Center Cellular Therapy; Hematology; GMP Cell Production
Claire Henchcliffe Weill Cornell Medical Center Neurodegenerative Disorders (PD); Biomarker Development; Clinical Trial Design
Mary Beth Henderson RCRI, Inc. Medical Device Regulatory and Quality System
Anthony Hollander University of Bristol Chondrogenesis; Osteoarthritis; Tissue Engineering; Trachea Engineering
Ole Isacson Harvard University Neurodegenerative Disease (PD, HD); Neuroregeneration
Robin Jenkins Sanofi-Aventis Medical Affairs; Global Development; Clinical Trial Data Management
Jane Johnson UT Southwestern Neurogenesis; Somatosensory Circuit; Pharmacology; Cancer Biology
Sadik Kassim Kite Pharmaceuticals Cancer Immunotherapy; CAR-T Cell Process Development; AAV Gene Therapy
Douglas Kerr Generatio Bio Neuronal Injury; Motor Neuron Disease; Neurodegeneration
Ali Khademhosseini Brigham and Women's Hospital Nanotechnologies for Controlling Cellular Behavior
Daniel Kim University of Texas Medical School at Houston Neurological Surgery; Spinal Surgery
Kathleen Kirby Viridian Strategies Clinical Operations; Gene Therapy & Biologics; Organ Indications
Vassilis Koliatsos Johns Hopkins University School of Medicine Traumatic & Degenerative Brain Injury and Repair; Alzheimer’s Disease
Olle Korsgren Uppsala University Hospital Islet Allo- & Xenotransplantation; Transplantation Immunology
Darrell Kotton Boston University Stem Cell & Gene Therapy; Lung Developmental Biology; Pulmonary Medicine
Paul Kulesa Stowers Institute for Medical Research Cell Migration, Imaging
Andrew Kung Columbia University Medical Center Tumor/Stem Cell Biology, Clinical Transplantation
John Kuo The University of Texas at Austin - Dell Medical School Neurosurgery; Neuro-oncology; Cancer Stem Cell Biology
Daniel Kuritzkes Harvard Medical School HIV-1 Persistence and Eradication; Resistance to Antiretroviral Drugs; Viral Fitness; Viral Tropism
Brian Kwon Vancouver General Hospital Spinal Cord Injury
John Lake University of Minnesota Liver, Solid Organ Transplantation
Joseph Laning Astellas Institute for Regenerative Medicine Cell Banking; Human Embryonic Stem Cell Banking
Jane Larkindale NMD Consulting Neuromuscular Disease; Patient Outreach; Venture Philanthropy
Russell Lonser Ohio State University Neurosurgery; Drug Delivery; Neural Disorders; Neuro-oncology
Christian Lorson University of Missouri Alternative Splicing; Spinal Muscular Atrophy; Gene Therapy
Pradeep Mammen University of Texas Southwestern Cardiology; Heart Failure/Transplantation; Neuromuscular Cardiomyopathy
Robert Marcus Independent Consultant Clinical & Drug Development in Osteoporosis & Bone Medicine
Robert Masson NeuroSpine Institute Neurosurgery; Bone & Spinal Surgery
William Matsui UT Austin Dell Medical School Regulatory Affairs; Clinical Development Strategy
John Mattick Garvan Institute of Medical Research Genetics & Genomics; Non-coding DNA
Margot Mayer-Proschel University of Rochester Glial Cells in Development, Disease, and Injury Repair
Jacob McCauley University of Miami Genetic Epidemiology; Multiple Sclerosis; Neurodegenerative Disease
Samir Mehta University of Pennsylvania Orthopaedic Trauma; Fractures; Articular Cartilage Injury
Alexander Meissner Max Planck Institute for Molecular Genetics Stem Cell Biology; Epigenetic and Cellular Reprogramming
Edmund Mickunas Independent Consultant Clinical & Regulatory Affairs for Pharmacologics, Biologics, and Medical Devices
Stephen Minger GE Healthcare Life Sciences Stem Cell Biology, Neurobiology; Cell Technologies
Shoukrhat Mitalipov Oregon Heath & Sciences University Gamete, Embryo, & Stem Cell Biology; Pluripotency
Bruce Montgomery Cardeas Pharma Product Development; Respiratory Disease
Christine Mummery Leiden University Medical Center Pluripotency & Differentiation to Cardiovascular Lineages
Michael Murphy Indiana University School of Medicine Vascular Surgery; Stem Cell Therapies for Cardiovascular Disease; Arterial & Aortic Disease
Richard Myers HudsonAlpha Institute for Biotechnology Genomics and Genetics of Human Diseases and Other Traits
Ulrik Nielsen Independent Consultant Cancer Immunotherapy; Adoptive T-Cell Therapy
Mark Noble University of Rochester Regenerative Medicine; Neural Stem Cells; Neurological Disease & Injury
Richard Ochoa Pre-Clinical Safety, Inc. Regulatory Affairs; Pharmacology & Toxicology
Maynard Olson University of Washington Genomics; Natural Variation in DNA Sequence
Kelly Otto Independent Consultant Clinical Drug Development; Clinical Operations
Sean Palecek University of Wisconsin Pluripotency; Tissue Engineering; Biosensors
Aarno Palotie Institute for Molecular Medicine Finland (FIMM) Genetics & the Central Nervous System; Migraines; Epilepsy; Schizophrenia; Autism
Nancy Parenteau Ingenium BioTherapy Corpporation Biotechnology; Biological Products; Drug Development
Malin Parmar Lund University Neurodegeneration & Parkinson’s Disease
David Pepperl Biologics Consulting Regulatory (Pharmacology/Toxicology)
Martin Pera The Jackson Laboratory Pluripotent Stem Cell Biology; Developmental Biology
Rita Perlingeiro University of Minnesota Lineage-Specific Differentiation (Skeletal); Genetic Correction of Disease
Michael Pfenning Mayo Clinic Hospital Operations & Clinical /Translational Research Administration
Seth Pollack Fred Hutchinson Cancer Research Center Oncology; Immunotherapy for Sarcoma; Adoptive T-Cell Therapy
Thomas Povsic Duke University Medical Center Cardiovascular Disease; Cell Therapy; Clinical Trial Design
Rajiv Raja MedImmune/Astra Zeneca Biomarker Development
Theodore Rasmussen University of Connecticut Chromatin Dynamics in Pluripotent Cells
Jared Roach Institute for Systems Biology High Throughput Systems Biology Data; Immunology; Neurodegeneration
Allan Robins Independent Consultant Cell Manufacturing and Process Development; Pluripotent Stem Cells; Cell Therapy Product Development
Frank Rockhold Duke University Biostatistics: Clinical Trial Design: Data Monitoring
Barry Rosen The Wellcome Trust Sanger Institute Mouse Genetics; Genetic Manipulation of ES Cells
Theodora Ross UT Southwestern Hematopoiesis; Leukemia
Anne Rosser Cardiff University CNS Regeneration (HD, PD)
Josh Rubin Washington University in St. Louis Pediatric Brain Tumors; Brain Development Mechanisms & Tumorigenesis
Steven Russell Massachusetts General Hospital Diabetes Research
Hesham Sadek University of Texas Southwestern Medical Center Cardiac & Hematopoietic Stem Cell Biology; Metabolomics; Microenvironment
Michel Sadelain Memorial Sloan-Kettering Cancer Center Gene Therapy; Bone Marrow Transplant; Immunology; Cancer
Jacqueline Sagen University of Miami Neural Transplantation; Axonal Regrowth; Chronic Pain Syndromes
Krishanu Saha University of Wisconsin-Madison Gene Editing, Biomanufacturing, Disease Modeling and Reprogramming
Vijay Sankaran Harvard Medical School Genetic Variation in Hematopoiesis and Blood Diseases
John-Michael Sauer Critical Path Institute Toxicology, Pharmacology, Drug Discovery & Development
Hans Scholer Max Plank Institute for Molecular Biomedicine Stem Cell Pluripotency & Germline Development
Brian Schwartz ArQule Oncology; Drug Development
James Schwob Tufts University Neural Development; Olfactory Projection; Neurogenesis
Christopher Scull Biologics Consulting Design and Management of IND-enabling Studies; Pre-clinical Regulatory Strategy
Khalid Shah Harvard Medical School Neuro-Oncology; Targeted Cancer Therapeutics; Stem Cell Transplantation
Warren Sherman Columbia Unversity Medical Center Cardiology; Cardiac-based Regenerative Medicine & Cellular Therapies
Robert Simari University of Kansas Medical Center Cardiology; Stem Cell & Regenerative Medicine Research
Kim Smith-Whitley Children’s Hospital of Philadelphia Pediatric Hematology; Sickle Cell Disease
Clifford Steer University of Minnesota Hepatology; Gene Therapy; miRNAs as Therapeutic Agents
Azim Surani Gurdon Institute Mammalian Germ Cells; Pluripotency; Epigenesis; Single Cell Technology
Viviane Tabar Memorial Sloan-Kettering Cancer Center Pluripotent & Neural Stem Cell Biology; Neurosurgery; Tumors
Alice Tomei University of Miami Cell and Tissue Engineering, Biomaterials, Type-1 Diabetes, Autoimmunity
Jay Traverse Minneapolis Heart Institute Stem Cell Therapy for Cardiovascular Disease
George Truskey Duke University Cardiovascular Engineering; Tissue Engineering; Stem Cells; Cell Mechanics
Stefan Tullius Brigham and Women’s Hospital Kidney/Pancreas Transplant Surgery; Transplantation Immunology
Ludovic Vallier University of Cambridge Pluripotent Stem Cell Biology; Endoderm; iPSC Modeling of Liver & Metabolic Disease
Richard Wade-Martins University of Oxford Molecular Mechanisms of Neurodegeneration; Gene Therapy
Herman Waldmann University of Oxford Transplantation Tolerance; Therapeutic use of Monoclonal Antibodies
Gordon Weir Joslin Diabetes Center Diabetes, Islet-cell Transplantation
Mitch Weiss St. Jude Children's Research Hospital Hematology; Genome Editing; Developmental Hematopoiesis
Barbara White Corbus Pharmaceuticals, Inc. Inflammatory and Autoimmune Disease, Rheumatology, Respiratory, and Dermatology
Theresa Whiteside University of Pittsburgh Cancer Institute Cancer Immunology and Immunotherapy, Cellular Therapy, Immunopathology
Scott Whittemore University of Louisville Spinal Cord Injury
Tom WIlkie UT Southwestern Medical Center Pancreatic Diseases, Diabetes, Stem Cell Transplantation and Cancer
Grant Williams Williams Cancer Drug Consulting, LLC Drug Development; Clinical Regulatory
Michelle LeRoux Williams Aziyo Biologics Drug & Product Development; Regulatory Affairs; Clinical Regulatory
Barbara Wirostko University of Utah Ophthalmology; Clinical Development
Cassian Yee University of Texas MD Anderson Cancer Center Medical Oncology; Immunology
Marco Zarbin New Jersey Medical School Opthamology; Cell Therapy
Wolfram-Hubertus Zimmerman University Medical Center Göttingen Cardiovascular Regenerative Medicine & Tissue Engineering
Juan Carlos Zúñiga-Pflücker University of Toronto Developmental Immunology, T-cells, Hematopoietic Stem Cells
Thomas Zwaka Mount Sinai School of Medicine Stem Cell Biology, Molecular Genetics